Records containing: Pulmonary Arterial Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-09-24A Prospective, Multicenter, Single-arm, Open-label, Phase 4 Study to Evaluate the Effects of Macitentan on Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension Assessed by Cardiac Magnetic Resonance Imaging
-
CLINICAL_TRIALS study record update · 2020-09-11The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Placebo-controlled, Phase 3b Study
-
CLINICAL_TRIALS study record update · 2020-09-09Using Either Intravenous (IV) or Subcutaneous (SQ) Treprostinil to Treat Pulmonary Hypertension Related to Underlying Interstitial Lung Disease
-
CLINICAL_TRIALS study record update · 2020-09-07An Open-label Extension of BPS-314d-MR-PAH-302 in Pulmonary Arterial Hypertension Patients
-
CLINICAL_TRIALS study record update · 2020-08-27Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-08-26Olaparib for Pulmonary Arterial Hypertension: a Pilot Clinical Study
-
CLINICAL_TRIALS study record update · 2020-07-27Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study
-
CLINICAL_TRIALS study record update · 2020-07-14A Randomized, Double-blind, Parallel-group, Placebo-controlled Phase 2 Trial of Ralinepag, an Oral IP Receptor Agonist, in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-06-16Effect of Pulmonary Arterial Hypertension Treatment on Obstructive Sleep Apnea
-
CLINICAL_TRIALS study record update · 2020-06-16Beta-blockers in Pulmonary Arterial Hypertension - A Phase 2 Double-Blind, Placebo-Controlled, Crossover Study Evaluating the Efficacy, and Safety of Carvedilol for Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-06-09A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients
-
CLINICAL_TRIALS study record update · 2020-05-20Metabolic Intervention in the Right Ventricle in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-03-30Combined Clinical and Surgical Approaches to Congenital Heart Disease Associated With Pulmonary Arterial Hypertension (PAH-CHD)
-
CLINICAL_TRIALS study record update · 2020-03-16LENUS Pro® Study (LPS-II) - Observation Study With Implantable Medication Pump for Intravenous REMODULIN® (Treprostinil) Therapy in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-03-09A Phase 2a, Double-Blind, Placebo-Controlled Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of RVT-1201 in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-03-03Hypotonic Treprostinil Subcutaneous Infusion for Control of Treprostinil Related Site Pain
-
CLINICAL_TRIALS study record update · 2020-02-28A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-02-28Long-term, Open Label, Multicenter, Extension Study to Evaluate the Safety and Tolerability of QCC374 in Patients With Pulmonary Arterial Hypertension (PAH)
-
CLINICAL_TRIALS study record update · 2020-02-13A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
-
CLINICAL_TRIALS study record update · 2020-02-05Effect of Pharmacologic Interaction Between Endothelin-Receptor-Antagonists and Phosphodiesterase-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients Wih Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-01-29Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2020-01-28Home-based Exercise Training in Patients With Pulmonary Arterial Hypertension: Effect on Skeletal Muscular Function and Metabolism
-
CLINICAL_TRIALS study record update · 2019-12-26An Open-Label Extension of BPS-MR-PAH-201 in Pulmonary Arterial Hypertension (PAH) Patients.
-
CLINICAL_TRIALS study record update · 2019-12-09Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2019-11-15The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study (The CAPS-PAH Study)